V019-1996 Screening compound: 2-{2-[(2,4-dichlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide

V019-1996 Screening compound: 2-{2-[(2,4-dichlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide
V019-1996 Screening compound: 2-{2-[(2,4-dichlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-1996
2-{2-[(2,4-dichlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-1996

Molecular Formula

C25H30Cl2N4O2 (C25 H30 Cl2 N4 O2)

Compound Name

2-{2-[(2,4-dichlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide

IUPAC name

2-{2-[(24-dichlorophenyl)methyl]-1H-13-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide

SMILES

CCCC(C(NCCN1CCOCC1)=O)n1c(cccc2)c2nc1Cc(ccc(Cl)c1)c1Cl

InChI

InChI=1S/C25H30Cl2N4O2/c1-2-5-23(25(32)28-10-11-30-12-14-33-15-13-30)31-22-7-4-3-6-21(22)29-24(31)16-18-8-9-19(26)17-20(18)27/h3-4,6-9,17,23H,2,5,10-16H2,1H3,(H,28,32)/t23-/m0/s1

InChI Key

RRLRVLFVFQJKKZ-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD19791247

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

489.44

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.112

Distribution Coefficient, logD

5.055

Water Solubility, LogSw

-5.52

Polar Surface Area

47.569

Acid Dissociation Constant (pKa)

13.05

Base Dissociation Constant (pKb)

6.55

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.00

V019-1996 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with V019-1996 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-1996?
Check Price and Availability of V019-1996, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-1996 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-1996
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-1996
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-1996 available by request